X
Search Filters
Format Format
Format Format
X
Sort by Item Count (A-Z)
Filter by Count
Journal Article (95905) 95905
Newspaper Article (32862) 32862
Patent (5700) 5700
Magazine Article (880) 880
Book Chapter (497) 497
Dissertation (380) 380
Trade Publication Article (321) 321
Web Resource (270) 270
Book / eBook (170) 170
Publication (106) 106
Conference Proceeding (73) 73
Newsletter (59) 59
Book Review (55) 55
Report (18) 18
Government Document (14) 14
Journal / eJournal (12) 12
Reference (7) 7
Transcript (3) 3
Paper (2) 2
Data Set (1) 1
Streaming Video (1) 1
more...
Subjects Subjects
Subjects Subjects
X
Sort by Item Count (A-Z)
Filter by Count
humans (75619) 75619
human papillomavirus (60678) 60678
female (48111) 48111
cervical cancer (35456) 35456
adult (26985) 26985
cancer (26239) 26239
middle aged (23112) 23112
oncology (22226) 22226
male (21910) 21910
vaccines (19777) 19777
immunization (15262) 15262
aged (14421) 14421
papillomavirus infections (13041) 13041
womens health (12055) 12055
adolescent (11600) 11600
risk factors (11295) 11295
research (11057) 11057
women (10833) 10833
animals (10387) 10387
health aspects (10335) 10335
papillomaviridae - genetics (9044) 9044
uterine cervical neoplasms - virology (8998) 8998
infections (8639) 8639
prevalence (8612) 8612
human-papillomavirus (8572) 8572
papillomavirus infections - virology (8484) 8484
papillomaviridae - isolation & purification (8392) 8392
young adult (8287) 8287
studies (8251) 8251
hpv (8242) 8242
immunology (8129) 8129
infection (7997) 7997
analysis (7488) 7488
microbiology (7300) 7300
dna (7182) 7182
risk (7004) 7004
infectious diseases (6999) 6999
medical screening (6914) 6914
pathology (6878) 6878
vaccination (6873) 6873
uterine cervical neoplasms - pathology (6764) 6764
medical research (6749) 6749
expression (6718) 6718
diagnosis (6658) 6658
tumors (6480) 6480
squamous cell carcinoma (6392) 6392
polymerase chain reaction (6387) 6387
virology (6300) 6300
papillomavirus infections - complications (6177) 6177
proteins (6102) 6102
obstetrics & gynecology (6057) 6057
squamous-cell carcinoma (5956) 5956
hygiene (5817) 5817
viruses (5717) 5717
papillomavirus infections - epidemiology (5705) 5705
human necessities (5700) 5700
prevention (5691) 5691
medical or veterinary science (5658) 5658
papillomavirus infections - prevention & control (5627) 5627
prognosis (5571) 5571
epidemiology (5538) 5538
aged, 80 and over (5510) 5510
preparations for medical, dental, or toilet purposes (5501) 5501
cell biology (5461) 5461
care and treatment (5353) 5353
research article (5252) 5252
carcinoma, squamous cell - pathology (5250) 5250
papillomavirus infections - diagnosis (5244) 5244
public health (5190) 5190
medicine (5102) 5102
dna, viral - analysis (5053) 5053
public, environmental & occupational health (5011) 5011
uterine cervical neoplasms - diagnosis (4969) 4969
deoxyribonucleic acid--dna (4955) 4955
surgery (4916) 4916
uterine cervical neoplasms - prevention & control (4883) 4883
mice (4835) 4835
chemistry (4818) 4818
carcinoma (4802) 4802
child (4767) 4767
medicine, research & experimental (4738) 4738
biochemistry (4682) 4682
gene expression (4550) 4550
immunohistochemistry (4500) 4500
peptides (4471) 4471
metallurgy (4387) 4387
biochemistry & molecular biology (4360) 4360
cervical-cancer (4341) 4341
genetic aspects (4324) 4324
retrospective studies (4254) 4254
apoptosis (4204) 4204
medicine, general & internal (4049) 4049
papillomaviruses (4047) 4047
carcinoma, squamous cell - virology (4007) 4007
cervix (3991) 3991
organic chemistry (3988) 3988
cervical intraepithelial neoplasia (3880) 3880
head (3848) 3848
lesions (3818) 3818
vaginal smears (3778) 3778
more...
Library Location Library Location
Library Location Library Location
X
Sort by Item Count (A-Z)
Filter by Count
Gerstein Science - Stacks (78) 78
Collection Dvlpm't (Acquisitions) - Vendor file (15) 15
Online Resources - Online (12) 12
UofT at Mississauga - Stacks (8) 8
Collection Dvlpm't (Acquisitions) - Closed Orders (6) 6
Sunnybrook Health Sciences Centre - Sunnybrook Stacks (6) 6
St. Michael's Hospital - Stacks (4) 4
New College (Ivey) - Stacks (3) 3
UofT at Scarborough - Stacks (2) 2
Dentistry (Harry R Abbott) - Stacks (1) 1
Gerstein Science - Reference (1) 1
Regis College - Stacks (1) 1
Robarts - Stacks (1) 1
St Josephs Health Centre - Stacks (1) 1
St. Augustine's Seminary - Stacks (1) 1
St. Michael's College (John M. Kelly) - 2nd Floor (1) 1
Trinity College (John W Graham) - Reference (1) 1
UofT at Scarborough - Reference Desk (1) 1
Victoria University E.J. Pratt - Stacks (1) 1
Women's College Hospital - Stacks (1) 1
more...
Language Language
Language Language
X
Sort by Item Count (A-Z)
Filter by Count
English (132239) 132239
French (2939) 2939
German (2054) 2054
Chinese (1180) 1180
Spanish (1058) 1058
Portuguese (887) 887
Japanese (464) 464
Russian (440) 440
Korean (359) 359
Polish (212) 212
Italian (181) 181
Danish (165) 165
Czech (106) 106
Norwegian (92) 92
Dutch (89) 89
Swedish (89) 89
Hungarian (76) 76
Turkish (62) 62
Finnish (55) 55
Bulgarian (43) 43
Croatian (40) 40
Ukrainian (33) 33
Slovenian (27) 27
Serbian (21) 21
Hebrew (20) 20
Slovak (18) 18
Persian (16) 16
Greek (13) 13
Icelandic (13) 13
Breton (12) 12
Lithuanian (12) 12
Romanian (11) 11
Estonian (7) 7
Bosnian (6) 6
Arabic (4) 4
Afrikaans (3) 3
Hindi (3) 3
Latvian (2) 2
Urdu (2) 2
Gaelic (1) 1
more...
Publication Date Publication Date
Click on a bar to filter by decade
Slide to change publication date range


The Lancet (British edition), ISSN 0140-6736, 2013, Volume 382, Issue 9895, pp. 889 - 899
Summary Cervical cancer is caused by human papillomavirus infection. Most human papillomavirus infection is harmless and clears spontaneously but persistent infection with high-risk human papillomavirus (especially type 16... 
Internal Medicine | WOMEN | POPULATION | MEDICINE, GENERAL & INTERNAL | PERSISTENCE | DNA | VACCINE | HPV INFECTION | FOLLOW-UP | RISK | CYTOLOGY | INTRAEPITHELIAL NEOPLASIA | Human papillomavirus 18 - immunology | Human papillomavirus 6 - immunology | Humans | Uterine Cervical Neoplasms - epidemiology | Human papillomavirus 11 - ultrastructure | Uterine Cervical Neoplasms - pathology | Human papillomavirus 16 - immunology | Human papillomavirus 6 - ultrastructure | Papillomavirus Infections - pathology | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Human papillomavirus 11 - immunology | Human papillomavirus 16 - ultrastructure | Human papillomavirus 11 - pathogenicity | Papillomavirus Vaccines - administration & dosage | Human papillomavirus 6 - pathogenicity | Human papillomavirus 16 - pathogenicity | Cross-Sectional Studies | Papillomavirus Infections - epidemiology | Uterine Cervical Neoplasms - prevention & control | Uterine Cervical Neoplasms - immunology | Vaginal Smears | Mass Screening | Virus Replication | Human papillomavirus 18 - pathogenicity | Papillomavirus Infections - prevention & control | Uterine Cervical Neoplasms - virology | Human papillomavirus 18 - ultrastructure | Papillomavirus Vaccines - immunology | Developing Countries | Cell Transformation, Neoplastic - pathology | Cell Transformation, Viral | Prevention | Papillomaviruses | Usage | Vaccines | Properties | Papillomavirus infections | Risk factors | Cervical cancer | Studies | Human papillomavirus | Immunization | Cellular biology | Womens health | Medical screening | Epidemiology | Age
Journal Article
Virology, ISSN 0042-6822, 2016, Volume 500, pp. 218 - 225
Abstract Human Papillomavirus E6 and E7 play critical roles in cancer development, although not all isolates of the viral oncoproteins are identical... 
Infectious Disease | pRb | CKII phosphorylation | TBP | HPV | ONCOPROTEIN | PROTEIN | HUMAN-PAPILLOMAVIRUS TYPE-16 | SEQUENCE VARIATION | PHOSPHORYLATION | RETINOBLASTOMA TUMOR-SUPPRESSOR | 16 E6 | E7 | COMPLEX-FORMATION | VIROLOGY | ADENOVIRUS E1A | DEGRADATION | Phosphorylation | Human papillomavirus 16 - physiology | Humans | Retinoblastoma Protein - metabolism | Amino Acid Motifs | Papillomavirus E7 Proteins - genetics | Papillomavirus Infections - genetics | TATA-Box Binding Protein - metabolism | Papillomavirus E7 Proteins - metabolism | TATA-Box Binding Protein - genetics | Papillomavirus Infections - metabolism | Retinoblastoma Protein - genetics | Protein Binding | Papillomavirus E7 Proteins - chemistry | Papillomavirus Infections - virology | Human papillomavirus 16 - chemistry | Binding Sites | Human papillomavirus 16 - genetics | Cell Transformation, Viral | Papillomavirus infections | Human papillomavirus 16/physiology | Papillomavirus Infections/virology | Papillomavirus Infections/metabolism | Papillomavirus E7 Proteins/metabolism | TATA-Box Binding Protein/metabolism | Retinoblastoma Protein/genetics | Virology | Life Sciences | Microbiology and Parasitology | Human health and pathology | TATA-Box Binding Protein/genetics | Papillomavirus E7 Proteins/chemistry | Human papillomavirus 16/chemistry | Papillomavirus E7 Proteins/genetics | Human papillomavirus 16/genetics | Retinoblastoma Protein/metabolism | Papillomavirus Infections/genetics | Cancer
Journal Article
Virus research, ISSN 0168-1702, 2017, Volume 231, pp. 108 - 118
•Preclinical animal papillomavirus (PV) models have established key foundational observations on HPV biology, viral gene function and host-virus interactions... 
Codon-modified viral genes | in vivo PV viral function | Innate immune responses to PV infections | Animal papillomavirus models | Vaccine and immunotherapeutics for PV infections | CPV | BPV | CRPV | MmuPV1 | OPEN READING FRAME | BOVINE PAPILLOMAVIRUS | Vaccine and immunotherapeutics for PV | COTTONTAIL RABBIT PAPILLOMAVIRUS | ORAL PAPILLOMAVIRUS | MHC CLASS-I | VIROLOGY | VIRAL-DNA | MOUSE MICROMYS-MINUTUS | infections | SQUAMOUS-CELL CARCINOMA | VIRUS-LIKE PARTICLES | DNA VACCINATION | Cottontail rabbit papillomavirus - genetics | Lambdapapillomavirus - genetics | Lambdapapillomavirus - growth & development | Bovine papillomavirus 1 - pathogenicity | Humans | Papillomavirus Vaccines - biosynthesis | Uterine Cervical Neoplasms - pathology | Cottontail rabbit papillomavirus - growth & development | Papillomaviridae - genetics | Bovine papillomavirus 1 - genetics | Papillomavirus Infections - pathology | Papillomaviridae - immunology | Skin Neoplasms - prevention & control | Cattle | Papillomavirus Infections - immunology | Female | Papillomavirus Infections - virology | Cottontail rabbit papillomavirus - immunology | Papillomavirus Vaccines - administration & dosage | Disease Models, Animal | Skin Neoplasms - pathology | Rabbits | Papillomaviridae - growth & development | Cottontail rabbit papillomavirus - pathogenicity | Skin Neoplasms - immunology | Uterine Cervical Neoplasms - prevention & control | Rats | Uterine Cervical Neoplasms - immunology | Lambdapapillomavirus - immunology | Primates - virology | Papillomaviridae - pathogenicity | Animals | Bovine papillomavirus 1 - growth & development | Papillomavirus Infections - prevention & control | Skin Neoplasms - virology | Dogs | Uterine Cervical Neoplasms - virology | Bovine papillomavirus 1 - immunology | Mice | Lambdapapillomavirus - pathogenicity | Medical colleges | Health aspects | Papillomavirus infections | Immunotherapy | Analysis | Medical research | AIDS vaccines | Codon | Viral proteins | Primates | Medicine, Experimental
Journal Article
The Lancet (British edition), ISSN 0140-6736, 2015, Volume 386, Issue 10008, pp. 2078 - 2088
...Introduction In 2008, one in six new cancer diagnoses worldwide was attributable to an infectious pathogen. Human papillomavirus (HPV) causes one-third... 
Internal Medicine | REGRESSION | MEDICINE, GENERAL & INTERNAL | ELECTROPORATION | METHYLATION | INTEGRATION | IMMUNOTHERAPY | E2 BINDING-SITES | NATURAL-HISTORY | CANCER | BURDEN | EXPRESSION | Human papillomavirus 18 - immunology | Humans | Papillomavirus E7 Proteins - immunology | Vaccines, DNA - immunology | Cervical Intraepithelial Neoplasia - drug therapy | Human papillomavirus 16 - immunology | Papillomavirus E7 Proteins - genetics | Young Adult | Cancer Vaccines - therapeutic use | Adult | Female | Oncogene Proteins, Viral - genetics | Papillomavirus Infections - virology | Human papillomavirus 18 - genetics | DNA-Binding Proteins - immunology | Papillomavirus Vaccines - therapeutic use | Double-Blind Method | Repressor Proteins - genetics | Treatment Outcome | Uterine Cervical Neoplasms - drug therapy | Vaccines, DNA - therapeutic use | DNA-Binding Proteins - genetics | Cervical Intraepithelial Neoplasia - virology | Cancer Vaccines - immunology | Repressor Proteins - immunology | Papillomavirus Infections - drug therapy | Uterine Cervical Neoplasms - virology | Papillomavirus Vaccines - immunology | Oncogene Proteins, Viral - immunology | Human papillomavirus 16 - genetics | Proteins | Cervix dysplasia | DNA | Clinical trials | Product development | Vaccines | Health aspects | Papillomavirus infections | Medical research | Analysis | Medicine, Experimental | Human papillomavirus | Immunization | Womens health | Immunotherapy | Genomes | Cervical cancer | Deoxyribonucleic acid--DNA
Journal Article
The New England journal of medicine, ISSN 1533-4406, 2009, Volume 361, Issue 19, pp. 1838 - 1847
Journal Article
International journal of cancer, ISSN 0020-7136, 07/2012, Volume 131, Issue 1, pp. 106 - 116
Journal Article